Want to see NAMS full AI Analyst Report?
NewAmsterdam Pharma Company (NAMS) Ownership Overview
6.22% Insiders
22.46% Mutual Funds
0.04% Other Institutional Investors
1.84% ETFs
69.44% Public Companies and
Individual Investors
The ownership structure of NewAmsterdam Pharma Company (NAMS) stock is a mix of institutional, retail, and individual investors. Approximately 24.34% of the company’s stock is owned by Institutional Investors, 6.22% is owned by Insiders, and 69.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 24, 2026 | xxxxxxxxxxxxx | $1208159 | |
May 27, 2026 | xxxxxxxxxxxxx | $2319850 | |
Mar 12, 2026 | xxxxxxxxxxxxx | $1357230 | |
Mar 10, 2026 | xxxxxxxxxxxxx | $513119 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $136515896 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $7729615 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $24081379 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $69986728 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,550,191 | Institution | 8.17% | 332,633,153 | |
| 8,396,080 | Institution | 7.18% | 292,435,466 | |
| 6,829,524 | Insider | 5.84% | 237,872,321 | |
| 4,264,789 | Institution | 3.65% | 148,542,601 | |
| 4,203,567 | Institution | 3.60% | 146,410,239 | |
| 3,425,823 | Institution | 2.93% | 119,321,415 | |
| 3,070,146 | Institution | 2.63% | 106,933,185 | |
| 2,186,402 | Institution | 1.87% | 76,152,382 | |
| 1,564,648 | Institution | 1.34% | 54,496,690 | |
| 1,463,192 | Institution | 1.25% | 50,962,977 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,396,080 | Institution | 7.18% | 292,435,466 | |
| 3,425,823 | Institution | 2.93% | 119,321,415 | |
| 1,564,648 | Institution | 1.34% | 54,496,690 | |
| 1,463,192 | Institution | 1.25% | 50,962,977 | |
| 1,232,500 | Institution | 1.05% | 42,927,975 | |
| 1,040,690 | Institution | 0.89% | 36,247,233 | |
| 957,477 | Institution | 0.82% | 33,348,924 | |
| 936,400 | Institution | 0.80% | 32,614,812 | |
| 534,102 | Institution | 0.46% | 18,602,773 | |
| 497,509 | Institution | 0.43% | 17,328,238 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 654,020 | Institution | 0.56% | 23,001,883 | |
| 573,244 | Institution | 0.49% | 19,966,089 | |
| 181,004 | Institution | 0.15% | 6,096,215 | |
| 121,148 | Institution | 0.10% | 4,219,585 | |
| 87,034 | Institution | 0.07% | 3,031,394 | |
| 42,775 | Institution | 0.04% | 1,440,662 | |
| 39,838 | Institution | 0.03% | 1,387,558 | |
| 39,052 | Institution | 0.03% | 1,360,181 | |
| 38,718 | Institution | 0.03% | 1,724,078 | |
| 34,652 | Institution | 0.03% | 1,206,929 |
FAQ
Who Owns Newamsterdam Pharma Company N.V. (NAMS)?
According to the latest TipRanks data, approximately 0.04% of the company's stock is held by institutional investors, 6.22% is held by insiders, and 69.44% is held by retail investors.
What percentage of Newamsterdam Pharma Company N.V. (NAMS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.04% of Newamsterdam Pharma Company N.V. (NAMS) stock is held by institutional investors.
What percentage of Newamsterdam Pharma Company N.V. (NAMS) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.44% of Newamsterdam Pharma Company N.V. (NAMS) stock is held by retail investors.
Who owns the most shares of Newamsterdam Pharma Company N.V. (NAMS)?
Peter Kolchinsky owns the most shares of Newamsterdam Pharma Company N.V. (NAMS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.